सामग्री पर जाएँ

दवाओं की अंतःक्रिया

Enzalutamide + Erdafitinib

गंभीरता: गंभीर

Enzalutamide and Erdafitinib: major interaction.

अंतिम अपडेट

केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।

इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।

सारांश

Enzalutamide is a strong CYP3A4 inducer and also induces CYP2C9. Erdafitinib is cleared by CYP2C9 and CYP3A4, so exposure may fall and its antitumor effect may be reduced.

इस इंटरैक्शन का सरल भाषा में अर्थ

Enzalutamide and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Enzalutamide belongs to Endocrine; Erdafitinib belongs to Oncology.

साक्ष्य स्तर: Moderate

ऐसा क्यों होता है

Induction of CYP3A4 and CYP2C9 by enzalutamide increases erdafitinib clearance.

क्या करें

Avoid coadministration where possible and consider an alternative to enzalutamide. If unavoidable, monitor serum phosphate and treatment response, as erdafitinib dosing is guided by phosphate and tolerability.

फार्मासिस्ट से क्या पूछें

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ सदस्यों के लिए

पूरा पेज खोलें

Enzalutamide और Erdafitinib की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।

अक्सर पूछे जाने वाले प्रश्न

Can I take Enzalutamide with Erdafitinib?

MediHelp rates the interaction as major. Enzalutamide and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Enzalutamide is a strong CYP3A4 inducer and also induces CYP2C9. Erdafitinib is cleared by CYP2C9 and CYP3A4, so exposure may fall and its antitumor effect may be reduced.

How serious is the interaction between Enzalutamide and Erdafitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration where possible and consider an alternative to enzalutamide. If unavoidable, monitor serum phosphate and treatment response, as erdafitinib dosing is guided by phosphate and tolerability.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर

MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।

A–Z ब्राउज़ करें · दवाओं की अंतःक्रिया

ऐप पाएँ साइन इन